Prevention of cardiovascular disease and diabetes: lessons from the Malmo Preventive Project

被引:36
作者
Nilsson, P [1 ]
Berglund, G [1 ]
机构
[1] Univ Hosp, Dept Internal Med, S-20502 Malmo, Sweden
关键词
alcohol; cardiovascular; evidence; hypertension; lipids; prevention;
D O I
10.1046/j.1365-2796.2000.00766.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Major public health problems such as cardiovascular disease and type 2 diabetes pose a challenge to both the medical profession and the health care system of most Western countries. In spite of widespread knowledge about risk factors and pathophysiological processes, it has been difficult to fmd effective preventive mass strategies-based on evidence from controlled clincial trials, In the Malmo Preventive Project, Sweden, 33 346 subjects were screened for risk factors between 1974 and 1992, and a quarter of them were offered preventive help for cardiovascular disease risk or alcohol abuse. The overall findings of the project was that benefits of screening and prevention on mortality risk could only be shown in certain subgroups of younger men and women, not in the total screened cohort, as compared with a nonscreened reference population These findings therefore question the effectiveness of preventive methods and drugs used during previous decades. New preventive methods are therefore needed and should be properly evaluated to form a basis for evidence-based prevention (EBP) in cardiovascular medicine.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 51 条
[31]  
PEDERSEN TR, 1994, LANCET, V344, P1383
[32]  
PETERSSON B, 1985, CIBA F SYMP, V110, P143
[33]   CHANGES IN CORONARY RISK-FACTORS DURING COMPREHENSIVE 5-YEAR COMMUNITY PROGRAM TO CONTROL CARDIOVASCULAR-DISEASES (NORTH-KARELIA-PROJECT) [J].
PUSKA, P ;
TUOMILEHTO, J ;
SALONEN, J ;
NEITTAANMAKI, L ;
MAKI, J ;
VIRTAMO, J ;
NISSINEN, A ;
KOSKELA, K ;
TAKALO, T .
BRITISH MEDICAL JOURNAL, 1979, 2 (6199) :1173-1178
[34]  
ROSENGREN A, 1987, ACTA MED SCAND, V221, P243
[35]   The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].
Sacks, FM ;
Pfeffer, MA ;
Moye, LA ;
Rouleau, JL ;
Rutherford, JD ;
Cole, TG ;
Brown, L ;
Warnica, JW ;
Arnold, JMO ;
Wun, CC ;
Davis, BR ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009
[36]   PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].
SHEPHERD, J ;
COBBE, SM ;
FORD, I ;
ISLES, CG ;
LORIMER, AR ;
MACFARLANE, PW ;
MCKILLOP, JH ;
PACKARD, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307
[37]   Influence of serum triglyceride levels on the risk for myocardial infarction in 12510 middle aged males:: interaction with serum cholesterol [J].
Stavenow, L ;
Kjellström, T .
ATHEROSCLEROSIS, 1999, 147 (02) :243-247
[38]  
Stearne MR, 1998, BMJ-BRIT MED J, V317, P703
[39]  
STRANDBERG TE, 1995, NUTR METAB CARDIOVAS, V5, P7
[40]  
*SWED COUNC TECHN, 1997, 134 SBU SWED COUNC T